Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis

Alimentary Pharmacology and Therapeutics

Volumn 43, Issue 7, 2016, Pages 825-830

  Von Arnim, U ^a   Wex, T ^a   Link, A ^a   Messerschmidt, M ^a   Venerito, M ^a   Miehlke, S ^b   Malfertheiner, P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Center for Digestive Diseases   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; BACTERIUM ANTIBODY;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIC ESOPHAGITIS; FEMALE; GENDER; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; SEROLOGY; SEROPREVALENCE; BLOOD; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MIDDLE AGED; RISK FACTOR; SEROEPIDEMIOLOGY; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIC ESOPHAGITIS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84959463728     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13560     Document Type: Article

References (43)

1. Liacouras CA, Furuta GT, Hirano I, et al,. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3-20.
2. Maradey-Romero C, Prakash R, Lewis S,., et al. The 2011-2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States. Aliment Pharmacol Ther 2015; 41: 1016-22
3. Hruz P, Straumann A, Bussmann C, et al,. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol 2011; 128: 1349-50.e5.
4. Cherian S, Smith NM, Forbes DA,. Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch Dis Child 2006; 91: 1000-4.
5. Shi YN, Sun SJ, Xiong LS, et al,. Prevalence, clinical manifestations and endoscopic features of eosinophilic esophagitis: a pathological review in China. J Dig Dis 2012; 13: 304-9.
6. Prasad GA, Alexander JA, Schleck CD, et al,. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009; 7: 1055-61.
7. Almansa C, Krishna M, Buchner AM, et al,. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol 2009; 104: 828-33.
8. Mackenzie SH, Go M, Chadwick B, et al,. Eosinophilic oesophagitis in patients presenting with dysphagia-a prospective analysis. Aliment Pharmacol Ther 2008; 28: 1140-6.
9. Dellon ES, Erichsen R, Baron JA, et al,. The increasing incidence and prevalence of eosinophilic esophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther 2015; 41: 662-70.
10. Fox VL, Nurko S, Furuta GT,. Eosinophilic esophagitis: it's not just kid's stuff. Gastrointest Endosc 2002; 56: 260-70.
11. Noel RJ, Putnam PE, Rothenberg ME,. Eosinophilic esophagitis. N Engl J Med 2004; 351: 940-1.
12. Roy-Ghanta S, Larosa DF, Katzka DA,. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2008; 6: 531-5.
13. Rothenberg ME,. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009; 137: 1238-49.
14. Kosunen TU, Hook-Nikanne J, Salomaa A, et al,. Increase of allergen-specific immunoglobulin E antibodies from 1973 to 1994 in a Finnish population and a possible relationship to Helicobacter pylori infections. Clin Exp Allergy 2002; 32: 373-8.
15. Sheikh A, Strachan DP,. The hygiene theory: fact or fiction? Curr Opin Otolaryngol Head Neck Surg 2004; 12: 232-6.
16. Chen Y, Blaser MJ,. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008; 198: 553-60.
17. Miehlke S, Hruz P, Vieth M, et al,. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut 2016; 65: 390-99.
18. Wex T, Venerito M, Kreutzer J, et al,. Serological prevalence of Helicobacter pylori infection in Saxony-Anhalt, Germany, in 2010. Clin Vaccine Immunol 2011; 18: 2109-12.
19. Dixon MF, Genta RM, Yardley JH, Correa P,. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
20. Bures J, Kopácová M, Koupil I, et al,. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter 2006; 11: 56-65.
21. Ponzetto A, Pellicano R, Morgando A, et al,. Seroprevalence of Helicobacter pylori infection among blood donors in Torino, Italy. Minerva Gastroenterol Dietol 2001; 47: 3-7.
22. Taylor DN,. Invited commentary: dynamics of Helicobacter pylori infection in childhood. Am J Epidemiol 1999; 150: 231-2; discussion 233-4.
23. Ronkainen J, Talley NJ, Aro P, et al,. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut 2007; 56: 615-20.
24. Dellon ES, Peery AF, Shaheen NJ, et al,. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology 2011; 141: 1586-92.
25. Furuta K, Adachi K, Aimi M, et al,. Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr 2013; 53: 60-2.
26. Elitsur Y, Alrazzak BA, Preston D, Demetieva Y,. Does Helicobacter pylori protect against eosinophilic esophagitis in children? Helicobacter 2014; 19: 367-71.
27. Kalach N, Huvenne H, Gosset P, et al,. Eosinophil counts in upper digestive mucosa of Western European children: variations with age, organs, symptoms, Helicobacter pylori status, and pathological findings. J Pediatr Gastroenterol Nutr 2011; 52: 175-82.
28. Malaty HM, El-Kasabany A, Graham DY, et al,. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002; 359: 931-5.
29. World Gastroenterology Organisation Global Guideline. Helicobacter pylori in developing countries. J Clin Gastroenterol 2011; 45: 383-8.
30. Strachan DP,. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-60.
31. Blaser MJ, Chen Y, Reibman J,. Does Helicobacter pylori protect against asthma and allergy? Gut 2008; 57: 561-7.
32. Herbarth O, Bauer M, Fritz GJ, et al,. Helicobacter pylori colonisation and eczema. J Epidemiol Community Health 2007; 61: 638-40.
33. Sonnenberg A, Lash RH, Genta RM,. A national study of H. pylori infection in gastric biopsy specimen. Gastroenterology 139: 1894-901
34. Blaser MJ,. Helicobacter and esophageal disease: wake-up call? Gastroenterology 2010; 139: 1819-22.
35. Eder W, Ege MJ, von Mutius E,. The asthma epidemic. N Engl J Med 2006; 355: 2226-35.
36. Straumann A, Bauer M, Fischer B, et al,. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001; 108: 954-61.
37. Wills-Karp M, Santeliz J, Karp CL,. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1: 69-75.
38. MacDonald TT, Monteleone I, Fantini MC, et al,. Regulation of homeostasis and inflammation in the intestine. Gastroenterology 2011; 140: 1768-75.
39. Lord JD,. Promises and paradoxes of regulatory T cells in inflammatory bowel disease. World J Gastroenterol 2015; 21: 11236-45.
40. Kandulski A, Malfertheiner P, Wex T,. Role of regulatory T-cells in H. pylori-induced gastritis and gastric cancer. Anticancer Res 2010; 30: 1093-103.
41. Zhu X, Wang M, Crump CH, et al,. An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice. Am J Physiol Gastrointest Liver Physiol 2009; 297: G550-8.
42. Stuck MC, Straumann A, Simon HU,. Relative lack of T regulatory cells in adult eosinophilic esophagitis-no normalization after corticosteroid therapy. Allergy 2011; 66: 705-7.
43. Fuentebella J, Patel A, Nguyen T, et al,. Increased number of regulatory T cells in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2010; 51: 283-9.